Home Carboxes 2587-00-0
2587-00-0,MFCD00130246
Catalog No.:AA0032YM

2587-00-0 | 2,6-Dichloropyridine N-Oxide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$25.00   $18.00
- +
5g
98%
in stock  
$87.00   $61.00
- +
25g
98%
in stock  
$260.00   $182.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0032YM
Chemical Name:
2,6-Dichloropyridine N-Oxide
CAS Number:
2587-00-0
Molecular Formula:
C5H3Cl2NO
Molecular Weight:
163.9894
MDL Number:
MFCD00130246
SMILES:
[O-][n+]1c(Cl)cccc1Cl
NSC Number:
136569
Properties
Properties
 
BP:
344.2°C at 760 mmHg  
Form:
Solid  
MP:
138-142 °C(lit.)  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
91  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
1  
XLogP3:
1.8  

Upstream Synthesis Route

[1]ChemicalandPharmaceuticalBulletin,1998,vol.46,#10,p.1656-1657

[2]JournalofHeterocyclicChemistry,2018,vol.55,#2,p.486-491

[3]JournalofOrganicChemistry,2011,vol.76,#19,p.7842-7848

[4]Synthesis,1980,#2,p.129-131

[1]Tetrahedron,2007,vol.63,#1,p.126-130

[1]OrganicLetters,1999,vol.1,#13,p.2077-2080

[1]OrganicLetters,1999,vol.1,#13,p.2077-2080

[1]OrganicLetters,1999,vol.1,#13,p.2077-2080

Downstream Synthesis Route

[1]Patent:CN103787964,2016,B.Locationinpatent:Paragraph0019-0020

[2]Patent:US2012/289497,2012,A1.Locationinpatent:Page/Pagecolumn51-52

[3]Patent:EP2524917,2012,A1.Locationinpatent:Page/Pagecolumn58

[4]AngewandteChemie-InternationalEdition,2013,vol.52,p.6277-6282    Angew.Chem.,2013,vol.125,p.6397-6402,6

[5]HeterocyclicCommunications,2016,vol.22,p.251-254

[6]Tetrahedron,2000,vol.56,p.5687-5698

[7]NewJournalofChemistry,2016,vol.40,p.9194-9204

[8]TetrahedronLetters,2008,vol.49,p.832-834

[9]Patent:US2006/241148,2006,A1.Locationinpatent:Page/Pagecolumn9

[10]AngewandteChemie-InternationalEdition,2016,vol.55,p.12321-12324    Angew.Chem.,2016,vol.128,p.12509-12512,4

[11]Chemicalandpharmaceuticalbulletin,1986,vol.34,p.3658-3671

[12]EuropeanJournalofMedicinalChemistry,2016,vol.109,p.294-304

[13]BioorganicandMedicinalChemistry,2018,vol.26,p.2051-2060

[14]JournalofOrganicChemistry,2018,vol.83,p.1510-1517

[15]Nucleosides,nucleotidesandnucleicacids,2003,vol.22,p.2133-2144

[16]Patent:US4631081,1986,A

[17]Patent:EP104876,1991,B1

[18]Patent:WO2012/97682,2012,A1.Locationinpatent:Page/Pagecolumn71-72

[19]Patent:WO2012/97479,2012,A1.Locationinpatent:Page/Pagecolumn145

[20]Patent:WO2012/97683,2012,A1.Locationinpatent:Page/Pagecolumn77

[21]Patent:US2013/211093,2013,A1.Locationinpatent:Paragraph0055

[22]BioorganicandMedicinalChemistry,2014,vol.22,p.1863-1872

[23]Patent:US2014/171429,2014,A1.Locationinpatent:Paragraph0329

[24]EuropeanJournalofMedicinalChemistry,2016,vol.121,p.352-363

[25]Patent:CN105294550,2016,A.Locationinpatent:Paragraph0045;0047

[1]ChemicalandPharmaceuticalBulletin,1998,vol.46,p.1656-1657

[2]JournalofHeterocyclicChemistry,2018,vol.55,p.486-491

[3]OrganicLetters,2020

[4]JournalofOrganicChemistry,2011,vol.76,p.7842-7848

[5]Synthesis,1980,p.129-131

[1]EuropeanJournalofMedicinalChemistry,2016,vol.109,p.294-304

[2]Patent:CN105294550,2016,A.Locationinpatent:Paragraph0045;0048

[3]BioorganicandMedicinalChemistry,2018,vol.26,p.2051-2060

[4]Chemicalandpharmaceuticalbulletin,1986,vol.34,p.3658-3671

[5]AngewandteChemie-InternationalEdition,2016,vol.55,p.12321-12324    Angew.Chem.,2016,vol.128,p.12509-12512,4

[6]NewJournalofChemistry,2016,vol.40,p.9194-9204

[7]Tetrahedron,2000,vol.56,p.5687-5698

[8]Patent:WO2012/97682,2012,A1.Locationinpatent:Page/Pagecolumn72

[9]Patent:WO2012/97479,2012,A1.Locationinpatent:Page/Pagecolumn145-146

[10]Patent:WO2012/97683,2012,A1.Locationinpatent:Page/Pagecolumn77

[11]BioorganicandMedicinalChemistry,2014,vol.22,p.1863-1872

[12]Patent:US2014/171429,2014,A1.Locationinpatent:Paragraph0330

[13]EuropeanJournalofMedicinalChemistry,2016,vol.121,p.352-363

[1]Tetrahedron,1981,vol.37,p.1787-1794

[1]JournalofOrganicChemistry,1980,vol.45,p.1347-1353

Literature

Title: Dichlororuthenium(IV) complex of meso-tetrakis(2,6-dichlorophenyl)porphyrin: active and robust catalyst for highly selective oxidation of arenes, unsaturated steroids, and electron-deficient alkenes by using 2,6-dichloropyridine N-oxide.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany) 20050620

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 2587-00-0
Tags:2587-00-0 Molecular Formula|2587-00-0 MDL|2587-00-0 SMILES|2587-00-0 2,6-Dichloropyridine N-Oxide |Organic_Building_Blocks